✦ LIBER ✦

Therapeutic Advances in Acute Myeloid Leukemia

✍ Scribed by Burnett, A.; Wetzler, M.; Lowenberg, B.

Book ID: 124068152
Publisher: American Society of Clinical Oncology
Year: 2011
Tongue: English
Weight: 192 KB
Volume: 29
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2010.30.1820

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel Therapeutics in Acute Myeloid Leuk

Novel Therapeutics in Acute Myeloid Leukemia

✍ Sweet, Kendra; Lancet, Jeffrey E. 📂 Article 📅 2014 🏛 Current Science Inc. 🌐 English ⚖ 228 KB

Novel therapeutic agents in acute myeloi

Novel therapeutic agents in acute myeloid leukemia

✍ Richard M. Stone 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Acute myeloid leukemia: advances in diag

Acute myeloid leukemia: advances in diagnosis and classification

✍ Hasserjian, R. P. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

Acute myeloid leukemia: Therapeutic impa

Acute myeloid leukemia: Therapeutic impact of epigenetic drugs

✍ Lucia Altucci; Nicole Clarke; Angela Nebbioso; Annamaria Scognamiglio; Hinrich G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Recent advances in management of acute m

Recent advances in management of acute myeloid leukemia (AML)

✍ Manasi Shah; Bharat Agarwal 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 198 KB

Acute myeloid leukemia in the elderly: b

Acute myeloid leukemia in the elderly: biology and therapeutic strategies

✍ A Pinto; V Zagonel; F Ferrara 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Age represents one of the most important adverse prognostic factors in acute myeloid leukemia (AML). The therapeutic results for patients older than 60 years accrued into clinical trials of intensive chemotherapy are largely unsatisfactory (complete remission rates rarely superior to 50-60%; median